Together, We're Working Wonders in Virginia
Frederick Frank, one of the most significant dealmakers in the biotech and pharma industry’s history and current vice chairman of Peter J. Solomon Company, will address the 2010 Mid-Atlantic Bio Conference(Oct. 27-29), on October 28, at the North ... read more ».
Senator Mark Warner would like to invite members of the Virginia Biotechnology Association to a conference he is hosting focused on expanding export opportunities for Virginia businesses, on Monday, September 13 from 8:30 am to 1:30 pm. The conference will feature a networking hour as well as ... read more ».
Promote your expertise and define yourself as a biotech thought leader by contributing to the BIO Program as a session speaker or organizer at the 2011 BIO International Convention, Monday – Thursday, June 27 – 30, 2011 in Washington DC. The 2011 BIO International Convention Call for ... read more ».
Six Virginia universities were selected by the U.S. Department of Education to receive and lead a STEM grant, of $28.5 million from the Invest in Innovation (i3) program to improve K-12 science education (science teaching and student learning) throughout the Commonwealth of Virginia, especially in ... read more ».
CW Optics, Inc., a privately held company specializing in design and development of biophotonic devices, has begun a clinical trial at Richmond’s Chippenham and Johnston-Willis (CJW) Medical Center to investigate the safety and efficacy of WoundImager®, an advanced optical imaging device for ... read more ».
LeClairRyan is accepting nominations for the 2011 SCOUT (Startup Companies Originating Unique Technology) award. The award is designed to recognize and assist an entrepreneur or emerging business with high growth potential. The recipient may receive up to $15,000 in complimentary legal services ... read more ».
As part of the previously announced transition plan for the leadership of Luna Innovations (NASDAQ: LUNA), Dr. Kent Murphy will step down as Chief Executive Officer and assume the role of Senior Strategic and Technology Advisor. Dr. Murphy will remain a member of the Board of Directors, serving in a ... read more ».
BioCity Nottingham, one of the United Kingdom’s fastest growing bioscience and healthcare business incubators and a recent collaborative partner of the Virginia Biotechnology Research Park, will be in town on Thursday, August 26, to discuss growth opportunities for companies considering expansion ... read more ».
CEL-SCI Corporation (NYSE AMEX: CVM), based in Vienna, Virginia, has successfully produced and filled its first lot of Multikine® in preparation for the upcoming pivotal Phase III trial targeting advanced primary head and neck cancer. The drug was filled in CEL-SCI’s state-of-the-art ... read more ».
Osteologix, Inc. (OTCBB: OLGX), has granted Servier Research Group, the leading French independent pharmaceutical company an exclusive royalty bearing license to develop and commercialize NB S101 (strontium malonate) to treat post menopausal osteoporosis, other bone and joint disorders and dental ... read more ».